J&J restructures pharma manufacturing footprint at cost of up to $750M news2026-07-15T16:48:54+00:00July 15th, 2026|Endpoints News|
Radiopharma maker AdvanCell hauls in $315M for Pluvicto challengernews2026-07-15T15:25:34+00:00July 15th, 2026|Endpoints News|
Insilico, Bora Pharma reveal plans for AI-driven manufacturing companynews2026-07-15T12:30:44+00:00July 15th, 2026|Endpoints News|
FDA proposes rule to simplify drugmakers’ factory registrationsnews2026-07-13T17:03:50+00:00July 13th, 2026|Endpoints News|
Catalent to divest UK site; Rottendorf, Evonik announce manufacturing buildsnews2026-07-09T13:43:02+00:00July 9th, 2026|Endpoints News|
Galderma gets CRL for anti-wrinkle drug; Kimball buys CDMO for $103Mnews2026-07-02T13:43:40+00:00July 2nd, 2026|Endpoints News|
FDA warns Genzyme’s Irish site over quality questionsnews2026-07-01T18:07:33+00:00July 1st, 2026|Endpoints News|
WuXi AppTec seeks injunction over China military listnews2026-07-01T17:52:54+00:00July 1st, 2026|Endpoints News|
Eli Lilly, Fujifilm among seven selected for FDA’s PreCheck pilotnews2026-06-30T17:12:43+00:00June 30th, 2026|Endpoints News|
